FLUVAC INNOVATOR vaccines deliver demonstrated protection against circulating contemporary equine influenza viruses (EIV). FLUVAC INNOVATOR vaccines aid in the prevention of equine influenza due to type A2 viruses, equine rhino pneumonitis due to equine herpes virus (EHV) types 1 and 4, equine encephalomyelitis due to Eastern, Western and Venezuelan viruses and tetanus. FLUVAC INNOVATOR is veterinarian's first choice for flu-rhino protection.
| Color |
: |
Pink |
| Compositions |
: |
Thimerosal, Polymyxin B, Formaldehyde, Clostridium tetani - Massachusetts (Cl.tetani), Eastern Equine Encephalomyelitis, Equine Influenza Virus, Kentucky 97 (EIV), Phosphate Buffered Saline, Poloxalene, Equine Herpesvirus-l, Equine Herpesvirus-4, Polysorbate 80, Western Equine Encephalomyelitis, Neomycin Free Base, Squalene |
| Form |
: |
Liquid |
| Net Content |
: |
1 mL |
- FLUVAC INNOVATOR is the only vaccine with EIV strain KY '97 that has demonstrated protection against heterologous challenge with EIV strain OH '03
- FLUVAC INNOVATOR is the only EIV vaccine shown to help protect against clinical signs for seven months against a heterologous, dual-strain challenge
- In addition to EIV, FLUVAC INNOVATOR vaccines also contain both EHV-1 and EHV-4 to help protect against rhinopneumonitis
- Only Innovator vaccines are adjuvant with MetaStim for improved immune response
- Inject 1 mL dose intramuscularly using aseptic technique
- Administer a second 1 mL dose 3 to 4 weeks after the first dose in unvaccinated or naive horses
- A 1 mL annual revaccination in previously vaccinated horses is recommended
- Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make exposure likely
- For veterinary use only
-
SDS
/ASSETS/DOCUMENTS/ITEMS/EN/https://assets.unilogcorp.com/187/ITEM/DOC/Zoetis_102797158_SDS.pdf